AGOURON PHARMACEUTICALS, LLC

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
 
 
C07D HETEROCYCLIC COMPOUNDS 7155
 
 
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 2253
 
 
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 148

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

  • No Recent Publications to Display

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
7429578 Tricyclic inhibitors of poly(ADP-ribose) polymerasesSep 06, 05Sep 30, 08[A61P]
7323562 Method of preparing poly(ADP-ribose) polymerases inhibitorsSep 21, 05Jan 29, 08[C07D]
7268126 Polymorphic and amorphous forms of the phosphate salt of 8-fluoro-2-{4-[(methylamino)methyl]phenyl}-1,3,4,5-tetrahydro-6H-azepino[-5,4,3-ce]indol-6-oneSep 21, 05Sep 11, 07[C07D]
7141581 Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their useAug 12, 03Nov 28, 06[C07D]
6977298 Tricyclic inhibitors of poly(ADP-ribose) polymerasesDec 03, 04Dec 20, 05[C07D]
6884890 Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their useFeb 13, 03Apr 26, 05[C07D]
6534524 Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their useOct 25, 01Mar 18, 03[A61K, C07D]
6495541 Tricyclic inhibitors of poly(ADP-ribose) polymerasesJan 10, 00Dec 17, 02[A61K, C07D]

Expired/Abandoned/Withdrawn Patents

  • No Patents to Display

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.